ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 372 filers reported holding ASTRAZENECA PLC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $122,370 | -11.5% | 1,807 | -6.4% | 0.00% | -20.0% |
Q2 2023 | $138,201 | +2.6% | 1,931 | -0.5% | 0.01% | 0.0% |
Q1 2023 | $134,655 | +22.4% | 1,940 | +19.6% | 0.01% | +25.0% |
Q4 2022 | $109,972 | +44.7% | 1,622 | +15.6% | 0.00% | +33.3% |
Q3 2022 | $76,000 | -13.6% | 1,403 | +5.4% | 0.00% | 0.0% |
Q2 2022 | $88,000 | +10.0% | 1,331 | +9.9% | 0.00% | -25.0% |
Q1 2022 | $80,000 | -2.4% | 1,211 | -15.3% | 0.00% | +100.0% |
Q4 2021 | $82,000 | -10.9% | 1,430 | -7.7% | 0.00% | -33.3% |
Q3 2021 | $92,000 | +9.5% | 1,550 | +8.8% | 0.00% | -40.0% |
Q2 2021 | $84,000 | +12.0% | 1,425 | -6.4% | 0.01% | +25.0% |
Q1 2021 | $75,000 | +2.7% | 1,523 | +4.0% | 0.00% | -20.0% |
Q4 2020 | $73,000 | +58.7% | 1,465 | +70.5% | 0.01% | +66.7% |
Q3 2020 | $46,000 | +2.2% | 859 | +0.9% | 0.00% | -25.0% |
Q2 2020 | $45,000 | +18.4% | 851 | -2.4% | 0.00% | 0.0% |
Q1 2020 | $38,000 | -24.0% | 872 | -14.8% | 0.00% | 0.0% |
Q4 2019 | $50,000 | +8.7% | 1,024 | -2.4% | 0.00% | 0.0% |
Q3 2019 | $46,000 | +12.2% | 1,049 | +4.0% | 0.00% | +33.3% |
Q2 2019 | $41,000 | -43.8% | 1,009 | -44.8% | 0.00% | -50.0% |
Q1 2019 | $73,000 | -36.5% | 1,828 | -40.3% | 0.01% | -40.0% |
Q4 2018 | $115,000 | -17.3% | 3,061 | -13.4% | 0.01% | -9.1% |
Q3 2018 | $139,000 | -31.5% | 3,535 | -39.1% | 0.01% | -35.3% |
Q2 2018 | $203,000 | -13.2% | 5,805 | -11.1% | 0.02% | -26.1% |
Q1 2018 | $234,000 | +3.1% | 6,533 | +0.3% | 0.02% | +4.5% |
Q4 2017 | $227,000 | +3.2% | 6,512 | +0.6% | 0.02% | -4.3% |
Q3 2017 | $220,000 | +11.7% | 6,471 | 0.0% | 0.02% | +9.5% |
Q2 2017 | $197,000 | +3.7% | 6,471 | +3.2% | 0.02% | -4.5% |
Q1 2017 | $190,000 | -18.8% | 6,271 | -16.3% | 0.02% | -26.7% |
Q4 2016 | $234,000 | 0.0% | 7,495 | 0.0% | 0.03% | 0.0% |
Q3 2016 | $234,000 | +6.8% | 7,495 | +2.7% | 0.03% | 0.0% |
Q2 2016 | $219,000 | -8.8% | 7,298 | -14.7% | 0.03% | +11.1% |
Q1 2016 | $240,000 | +14.8% | 8,559 | +38.8% | 0.03% | -27.0% |
Q4 2015 | $209,000 | -3.2% | 6,168 | -9.2% | 0.04% | +12.1% |
Q3 2015 | $216,000 | +64.9% | 6,792 | +228.3% | 0.03% | +73.7% |
Q2 2015 | $131,000 | +26.0% | 2,069 | +35.8% | 0.02% | +26.7% |
Q1 2015 | $104,000 | +4.0% | 1,524 | +7.8% | 0.02% | 0.0% |
Q4 2014 | $100,000 | -1.0% | 1,414 | -0.8% | 0.02% | -6.2% |
Q3 2014 | $101,000 | -3.8% | 1,425 | 0.0% | 0.02% | +6.7% |
Q2 2014 | $105,000 | -19.2% | 1,425 | -29.7% | 0.02% | -16.7% |
Q1 2014 | $130,000 | +15.0% | 2,028 | +9.5% | 0.02% | +5.9% |
Q4 2013 | $113,000 | +289.7% | 1,852 | +230.1% | 0.02% | +240.0% |
Q3 2013 | $29,000 | +7.4% | 561 | -2.1% | 0.01% | -64.3% |
Q2 2013 | $27,000 | -15.6% | 573 | -9.2% | 0.01% | -22.2% |
Q1 2013 | $32,000 | -3.0% | 631 | -10.7% | 0.02% | -21.7% |
Q4 2012 | $33,000 | -5.7% | 707 | -3.0% | 0.02% | -17.9% |
Q3 2012 | $35,000 | -22.2% | 729 | -25.8% | 0.03% | -20.0% |
Q2 2012 | $45,000 | -23.7% | 982 | -25.5% | 0.04% | -28.6% |
Q1 2012 | $59,000 | – | 1,319 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |